The present objective of prevention is the eradication of<unk> , which is achievable since the disease has no known animal reservoir. The World Health Organization recommends mass deworming—treating entire groups of people who are at risk with a single annual dose of two medicines, namely albendazole in combination with either ivermectin or diethylcarbamazine citrate. With consistent treatment, since the disease needs a human host, the reduction of microfilariae means the disease will not be transmitted, the adult worms will die out, and the cycle will be broken. In sub-Saharan Africa, albendazole (donated by GlaxoSmithKline) is being used with ivermectin (donated by Merck & Co.) to treat the disease, whereas elsewhere in the world, albendazole is used with diethylcarbamazine. As of 2019 WHO recommends prevention with a combination of ivermectin, diethylcarbamazine, and albendazole in areas were onchocerciasis does not occur. Transmission of the infection can be broken when a single dose of these combined oral medicines is consistently maintained annually for a duration of four to six years. Using a combination of treatments better reduces the number of microfilariae in blood. Avoiding mosquito bites, such as by using insecticide-treated mosquito bed nets, also reduces the transmission of<unk> . The Carter Center's International Task Force for Disease Eradication declared<unk>  one of six potentially eradicable diseases. On 29 October 2020, the World Health Organization announced that "targets for 2030 are that 80% of endemic countries have met the criteria for validation of elimination as a public health problem, with the remaining 20% under post-treatment surveillance." (wikilinks added) For similar-looking but causally unrelated podoconiosis, international awareness of the disease will have to increase before elimination is possible. In 2011, podoconiosis was added to the World Health Organization's Neglected tropical diseases list, which was an important milestone in raising global awareness of the condition. The efforts of the Global Programme to Eliminate<unk>  are estimated to have prevented 6.6 million new<unk>  cases from developing in children between 2000 and 2007, and to have stopped the progression of the disease in another 9.5 million people who had already contracted it. Dr. Mwele Malecela, who chairs the programme, said: "We are on track to accomplish our goal of elimination by 2020." In 2010, the WHO published a detailed progress report on the elimination campaign in which they assert that of the 81 countries with endemic<unk> , 53 have implemented mass drug administration, and 37 have completed five or more rounds in some areas, though urban areas remain problematic.
Lymphatic filariasis
Isosporiasis
Loa loa filariasis
Leishmaniasis
Onchocerciasis
Paragonimiasis
Toxocariasis
Cyclosporiasis